Chaddy, Scotts presentation in November 2023 had a slide headed " Pathway to market entry ( Gen 1 during FY25)".
Since then; the company has continued to tick milestones, received a strategic investment from Keysight technologies (MC $26b US), strengthened the Board, and confirmed that preparations are well advanced for a pre-submission meeting with the FDA.
Things can always go wrong however this is a careful, considered company with top notch management.
EMV Price at posting:
$2.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)